FMP
ProShares Ultra Nasdaq Biotechnology
BIB
NASDAQ
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
52.58 USD
2.13 (4.05%)
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
N/A
exchange
NASDAQ
Description
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
CIK
0001174610
ISIN
US74347R2141
CUSIP
74347R214
Address
N/A
Phone
NA
Country
US
Employee
N/A
IPO Date
Apr 9, 2010
Key Executives
